Insider Stock Trading History of Countouriotis Athena


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Countouriotis Athena since year 2005. The trader's CIK number is 1571469. At the time of this reporting, Countouriotis Athena is the SVP and Chief Medical Officer of Halozyme Therapeutics Inc . (stock ticker symbol HTI). See this page for all insider trading activities at Halozyme Therapeutics Inc .


Stock purchases, sales, and option exercises reported by insider Countouriotis Athena since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-02-03 HALO Halozyme Therapeutics Inc Option Ex 18,496 .00 0
2017-01-05 HALO Halozyme Therapeutics Inc Option Ex 7,500 .00 0
2016-06-30 HALO Halozyme Therapeutics Inc Option Ex 6,450 .00 0
2016-01-05 HALO Halozyme Therapeutics Inc Option Ex 7,500 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Countouriotis Athena (SVP and Chief Medical Officer of Halozyme Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.